Bio-Techne (TECH) Capital Expenditures Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | -8.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.21% |
| Dec 31, 2025 | -1.04% |
| Sep 30, 2025 | -17.51% |
| Jun 30, 2025 | -28.84% |
| Mar 31, 2025 | -12.48% |
| Dec 31, 2024 | -12.46% |
| Sep 30, 2024 | 14.75% |
| Jun 30, 2024 | 16.69% |
| Mar 31, 2024 | 15.75% |
| Dec 31, 2023 | 9.10% |
| Sep 30, 2023 | 7.51% |
| Jun 30, 2023 | -14.57% |
| Mar 31, 2023 | 8.17% |
| Dec 31, 2022 | -25.14% |
| Sep 30, 2022 | -3.17% |
| Jun 30, 2022 | 5.09% |
| Mar 31, 2022 | 45.27% |
| Dec 31, 2021 | 30.23% |
| Sep 30, 2021 | 13.15% |
| Jun 30, 2021 | 24.83% |
| Mar 31, 2021 | 44.58% |
| Dec 31, 2020 | 21.79% |
| Sep 30, 2020 | 27.53% |
| Jun 30, 2020 | 43.59% |
| Mar 31, 2020 | 32.22% |
| Dec 31, 2019 | 72.18% |
| Sep 30, 2019 | 62.74% |
| Jun 30, 2019 | 56.44% |
| Mar 31, 2019 | 20.20% |
| Dec 31, 2018 | -1.97% |
| Sep 30, 2018 | -11.87% |
| Jun 30, 2018 | -5.68% |
| Mar 31, 2018 | -10.69% |
| Dec 31, 2017 | 26.33% |
| Sep 30, 2017 | 2.44% |
| Jun 30, 2017 | 40.81% |
| Mar 31, 2017 | -1.95% |
| Dec 31, 2016 | -7.86% |
| Sep 30, 2016 | -13.79% |
| Jun 30, 2016 | -17.03% |
| Mar 31, 2016 | -23.65% |
| Dec 31, 2015 | -15.91% |
| Sep 30, 2015 | 34.51% |
| Jun 30, 2015 | 82.92% |
| Mar 31, 2015 | 45.85% |
| Dec 31, 2014 | 12.60% |
| Sep 30, 2014 | 64.79% |
| Jun 30, 2014 | 18.20% |
| Mar 31, 2014 | 93.08% |
| Dec 31, 2013 | 72.30% |
| Sep 30, 2013 | 53.58% |
| Jun 30, 2013 | 68.22% |
| Mar 31, 2013 | 67.10% |
| Dec 31, 2012 | 72.84% |
| Sep 30, 2012 | 64.69% |